FDA to Reconsider Ban on 7 Peptides in July After Pressure from Pharma Lobbying BigGo Finance Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas